Vertex Pharmaceuticals (VRTX) Financials

$549.06

$-8.90 (-1.60%)

As on 04-Sep-2026 13:39EDT

Market cap

$137,210 Mln

Revenue (TTM)

$12,624 Mln

P/E Ratio

31.5

P/B Ratio

6.9

Div. Yield

0 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	12,624.30	12,074.60	11,020.10	9,869.20	8,930.70	7,574.40
Cost of Revenue	1,762.80	1,807.10	1,530.50	1,262.20	1,080.30	904.20
Gross Profit	10,861.50	10,267.50	9,489.60	8,607.00	7,850.40	6,670.20
Operating Expenses	5,989.90	5,506.80	9,722.50	4,775.00	3,543.00	3,891.20
Operating Profit (EBIT)	4,872.00	4,760.70	-232.90	3,832.00	4,307.40	2,782.10
Other Income	--	--	--	--	-20.20	9.80
Profit before Tax	5,274.90	4,643.20	248.50	4,379.80	4,232.40	2,730.40
Provision for Tax	869.30	690.00	784.10	760.20	910.40	388.30
Profit after Tax (Net Income)	4,405.20	3,953.20	-535.60	3,619.60	3,322.00	2,342.10
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	3,322.00	2,342.10

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	20,247.90	18,665.80	16,409.60	17,580.40	13,912.70	10,100.00
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	3,237.50	3,615.80	2,559.00	1,602.40	1,496.10	1,190.50
Current Liabilities	3,937.90	3,861.20	3,564.60	3,547.40	2,742.10	2,142.00
Total Liabilities	31,361.20	26,142.80	22,533.20	22,730.20	18,150.90	13,432.50

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	14,879.60	14,941.80	12,936.80	8,586.00	4,916.10	3,871.90
Current Assets	12,543.70	11,201.00	9,596.40	14,144.20	13,234.80	9,560.60
Total Assets	31,361.20	26,142.80	22,533.20	22,730.20	18,150.90	13,432.50
Total Debt*	1,977.60	3,882.50	1,749.50	808.40	899.70	967.40
Net Current Assets	8,605.80	7,339.80	6,031.80	10,596.80	10,250.70	7,141.20

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	3,631.40	-492.60	3,537.30	4,129.90	2,643.50
Cash Flow from Investing Activities	--	-945.40	-3,770.00	-3,141.70	-321.10	-340.90
Cash from Financing Activities	--	-2,261.30	-1,494.90	-562.20	-67.70	-1,478.00
Net Cash Inflow / Outflow	--	--	--	--	3,741.10	824.60

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	17.18	15.44	-2.06	13.87	12.76	9.11
Cash EPS ($)	--	16.26	-1.26	14.57	13.33	9.60
Adjusted Book Value ($)	--	72.88	62.99	67.38	53.45	39.30
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	14.18	-1.89	13.56	15.87	10.29
Free Cash Flow per Share ($)	--	12.47	-3.03	12.57	15.08	9.37

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	19.42	-2.93	21.80	25.67	22.64
ROE (%)	22.64	22.54	-3.15	22.99	27.67	24.93
ROA (%)	14.80	16.24	-2.37	17.71	21.04	18.60
EBIT Margin (%)	41.83	38.56	2.55	44.83	48.01	36.86
Net Margin (%)	34.89	32.74	-4.86	36.68	37.28	30.88
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	10.56	0.10	0.12	0.11	0.18	0.22
EBIT Growth (%)	20.31	1,560.07	-93.66	3.19	53.56	-12.06
Net Profit Growth (%)	21.10	838.09	-114.80	8.96	41.84	-13.63
EPS Growth (%)	22.80	8.51	-1.15	0.09	0.40	-0.12
Book Value Growth (%)	19.36	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	31.51	29.37	-195.86	29.33	22.63	24.10
Price / Book Value	6.85	6.22	6.39	6.04	5.40	5.59
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	26.06	23.31	206.74	20.79	14.72	17.10
Close Price ($)	496.73	453.36	402.70	406.89	288.78	219.60
High Price ($)	507.92	519.68	519.88	413.00	324.75	242.99
Low Price ($)	362.50	362.50	378.00	282.21	214.66	176.36
Market Cap ($ Cr)	137,210.08	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	--	0.21	0.11	0.05	0.06	0.10
Short term debt to equity ratio	--	0.00	0.01	0.00	0.01	0.01
Current Ratio	3.19	2.90	2.69	3.99	4.83	4.46
Quick Ratio	2.74	2.46	2.35	3.78	4.66	4.30
Interest Coverage	800.23	350.11	9.17	100.32	78.23	45.40

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	16.91	17.00	14.60	15.84	16.15	15.01
Asset Turnover	0.42	0.50	0.49	0.48	0.57	0.60
Receivable days	--	55.39	52.58	55.62	52.74	48.76
Inventory Days	--	292.28	231.99	173.54	137.56	128.03
Payable days	--	88.40	92.82	96.77	84.34	70.71
Cash Conversion Cycle	--	259.28	191.75	132.39	105.96	106.07

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)